Absence of occult hepatitis B among blood donors in southern Brazil

Brazilian Journal of Infectious Diseases

Volumn 15, Issue 2, 2011, Pages 159-162

  Wolf, Fernando Herz ^a,b   Fuchs, Sandra Costa ^a,b,c   Brandão, Ajacio B M ^b,c,d  

^a National Institute of Science and Technology for Health Technology Assessment (IATS) CNPq   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Blood donors; Hepatitis B; Hepatitis B virus; Seroepidemiologic studies

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BLOOD STORAGE; BRAZIL; CONTROLLED STUDY; DNA EXTRACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FREEZE THAWING; HEPATITIS B; HUMAN; OCCULT HEPATITIS B; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; STORAGE TEMPERATURE;

EID: 79959579783     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1590/S1413-86702011000200012     Document Type: Article

References (23)

1. Torbenson M, Tomas DL. Occult hepatitis B. Lancet Infect Dis 2002; 2:479-86.
2. Bowden S, Bartholomeusz A, Locarnini S. Lamivudine resistant occult HBV: implications for public health? J Hepatol 2003; 38:526-8.
3. Bréchot C, Tiers V, Kremsdorf D et al. Persistent Hepatitis B Virus Infection in Subjects Without Hepatitis B Surface Antigen: Clinically Significant or Purely "Occult"? Hepatology 2001; 34:194-203.
4. Souza LO, Pinho JR, Carrilho FJ, da Silva LC. Absence of hepatitis B virus DNA in patients with hepatitis C and non-A-E hepatitis in the State of São Paulo, Brazil. Braz J Med Biol Res 2004; 37:1665-8.
5. Alencar RS, Gomes MM, Sitnik R et al. Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil. Braz J Med Biol Res 2008; 41:235-40.
6. Shetty K, Hussain M, Nei L, Reddy KR, Lok AS. Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C. Liver Transpl 2008; 14:534-40
7. Brandão ABM, Fuchs SC. Risk Factors for hepatitis C infecton among blood donors in southern Brazil: a case-control study. BMC Gastroenterol 2002; 2:18.
8. Kramvis A, Bukofzer S, Kew MC. Comparison of Hepatitis B Virus DNA Extractions from Serum by the QIAamp Blood Kit, GeneReleaser, and the Phenol-Chloroform Method J. Clin. Microbiol 1996; 34:2731-3.
9. Pas SD, Fries E, de Man RA, Osterhaus ADME, Niester HGM. Development of a Quantitative Real-Time Detection Assay for Hepatitis B Virus DNA and Comparison with Two Commercial Assays. J. Clin. Microbiol 2000; 38:2897-901.
10. Branco F, Mattos AA, Coral GP et al. Occult hepatitis B virus infection in patients with chronic liver disease due to hepatitis C virus and hepatocellular carcinoma in Brazil. Arq Gastroenterol 2007; 44:58-63.
11. Krajden M, Minor JM, Rifin O, Comanor L. Efect of Multiple Freeze-Taw Cycles on Hepatitis B Virus DNA and Hepatitis C Virus RNA Quantification as Measured with Branched-DNA Technology. J Clin Microbiol 1999; 37:1683-6.
12. Cacciola I, Pollicino T, Squadrito G et al. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341:22-6;
13. Fukuda R, Ishimura N, Niigaki M et al. Serologically silent hepatitis B virus co-infection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J Med Virol 1999; 58:201-7.
14. Mrani S, Chemin I, Menouar K et al. Occult HBV infection may represent a major risk factor of nonresponse to antiviral therapy of chronic hepatitis C. J Med Virol 2007; 79: 1075-81.
15. Paterlini P, Driss F, Nalpas B et al. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HB-sAg-negative patients: a study of a low-endemic area. Hepatology 1993; 17:20-9.
16. Takeuchi M, Fujimoto J, Niwamoto H, Yamamoto Y, Okamoto E. Frequent detection of hepatitis B virus X-gene DNA in hepatocellular carcinoma and adjacent liver tissue in hepatitis B surface antigennegative patients. Dig Dig Sci 1997; 42:2264-9.
17. Lee DS, Huh K, Lee EH et al. HCV and HBV coexist in HB-sAg-negative patients with HCV viraemia: possibility of co-infection in these patients must be considered in HBV-high endemic area. J Gastroenterol Hepatol 1997; 12:855-61.
18. Koike K, Tsutsumi T, Fujie H, Shintani Y, Kyoji M. Molecular mechanism of viral hepatocarcinogenesis. Oncology 2002; 62 (S1):29-37.
19. Satake M, Taira R, Yugi H et al. Infectivity of blood components with low hepatitis B virus DNA levels identifed in a lookback program. Transfusion 2007; 47:1197-205.
20. Candotti D, Allain J P. Transfusion-transmitted hepatitis B virus infection. J Hepatol 2009; 51:798-809.
21. Lok ASF, Liang RHS, Chiu EKW et al. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1999; 100:182-8.
22. Wu JM, Huang YH, Lee PC, Lin HC, Lee SD. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody body positive before receiving chemotherapy for non-Hodgkin lymphoma. J Clin Gastroenterol 2009; 43:496-8.
23. Bloquel B, Jeulin H, Burty C et al. Occult hepatitis B infection in patients infected with HIV: report of two cases of hepatitis B reactivation and prevalence in a hospital cohort. J Med Virol 2010; 82:206-12.